Encompass Health Cash Flow Statement
NYSE: EHCHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Encompass Health free cash flow
In fiscal 2025, Encompass Health generated $1.18 billion of operating cash flow and spent $736.4 million on capital expenditures. That left free cash flow of $439.2 million, a free-cash-flow margin of 7.4% of revenue. Free cash flow was up 21.9% from the prior year's $360.3 million.
Encompass Health returned $229.1 million to shareholders: $71.1 million in dividends and $158.0 million in share repurchases, equal to 52% of free cash flow. Free cash flow covered dividend payments 6.2 times.
Summary generated from market data by MetaCap's automated system. Methodology
Encompass Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 759.10M | 596.60M | 463.00M | 365.90M | 517.20M | 368.80M | 445.80M | 375.40M | 350.20M | 318.10M |
| Net Income growth (YoY) | +27.24% | +28.86% | +26.54% | -29.25% | +40.24% | -17.27% | +18.75% | +7.20% | +10.09% | +25.83% |
| Depreciation & Amortization | 327.90M | 299.60M | 273.90M | 243.60M | 219.60M | 203.00M | 218.70M | 199.70M | 183.80M | 172.60M |
| Stock-Based Compensation | 56.50M | 48.30M | 50.60M | 29.20M | 29.10M | 25.60M | 114.40M | 85.90M | 47.70M | 27.40M |
| Change in Working Capital | -11.60M | 1.50M | 11.10M | 800.00K | -79.50M | 14.10M | -193.30M | 31.20M | -31.80M | -51.50M |
| Operating Cash Flow | 1.18B | 1.00B | 850.80M | 705.80M | 715.80M | 704.70M | 635.30M | 762.40M | 658.30M | 640.20M |
| Capital Expenditures | -736.40M | -642.50M | -583.10M | -564.80M | -524.60M | -392.80M | -372.40M | -254.50M | -225.80M | -177.70M |
| Investing Cash Flow | -764.60M | -653.30M | -602.80M | -627.00M | -666.30M | -407.50M | -657.40M | -424.50M | -283.00M | -229.90M |
| Dividends Paid | -71.10M | -62.80M | -60.40M | -99.00M | -112.20M | -111.80M | -108.70M | -100.80M | -91.50M | -83.80M |
| Share Repurchases | -158.00M | -31.10M | 0 | 0 | 0 | -6.10M | -45.90M | 0 | -38.10M | -65.60M |
| Debt Issued | — | — | — | 0 | 0 | 992.50M | 1.00B | 0 | 0 | 0 |
| Debt Repaid | -115.10M | -255.20M | -7.20M | -345.80M | -214.50M | -717.20M | -519.50M | -20.60M | -129.90M | -202.10M |
| Financing Cash Flow | -431.20M | -330.60M | -197.20M | -145.70M | -240.10M | -145.90M | 48.20M | -321.20M | -359.90M | -416.40M |
| Net Change in Cash | -20.20M | 18.90M | 50.80M | -66.90M | -190.60M | 151.30M | 26.10M | 16.70M | 15.40M | -6.10M |
| Free Cash Flow | 439.20M | 360.30M | 267.70M | 141.00M | 191.20M | 311.90M | 262.90M | 507.90M | 432.50M | 462.50M |
This table shows 10 annual periods of Encompass Health's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow EHC's reporting calendar. What is a cash flow statement?